Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication
视网膜母细胞瘤蛋白介导的雄激素受体转录抑制活性对DNA复制的机制研究
基本信息
- 批准号:10245265
- 负责人:
- 金额:$ 34.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-25 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Androgen ReceptorAndrogensAutomobile DrivingCell CycleCell Cycle ProgressionChIP-seqChromatinChromatin StructureClinicalComplexCyclin-Dependent KinasesDNA biosynthesisDiseaseDoseGene ActivationGene ExpressionGenesGenetic TranscriptionGrowthKDM1A geneLipidsMalignant neoplasm of prostateMediatingMetabolicMolecularPatientsPhosphorylationPlayRecruitment ActivityRelapseReportingRepressionRepressor ProteinsRetinoblastoma ProteinRoleSamplingSiteSterolsTranscription CoactivatorTranscription RepressorTranscriptional ActivationTumor Suppressor Proteinsandrogen deprivation therapyandrogen sensitivecastration resistant prostate cancergene repressiongenome-widegenome-wide analysisin vivoinhibitor/antagonistneoplastic celloverexpressionpreventpromoterprostate cancer cellprostate cancer modelprostate cancer progressionprotein complexrecruittranscriptometumor
项目摘要
Project Summary
While AR has been extensively characterized as a transcriptional activator, it was recently reported to
function as a transcriptional repressor to suppress a subset of genes. Significantly, through AR ChIP-seq and
transcriptome profiling in prostate cancer cells we have found that the directly AR-repressed genes are highly
enriched for DNA replication function and majority of those genes were consistently increased in CRPC clinical
samples. We then discovered that this direct transcriptional repression activity of AR was mediated by
androgen-stimulated recruitment of hypophosphorylated Rb. Androgens is also known to stimulate growth by
further AR transcriptional activation of genes driving lipid and sterol synthesis, and other metabolic functions,
with subsequent cyclin dependent kinase activation and Rb hyperphosphorylation. Overexpression of AR in
prostate cancer cells could overcome this growth stimulatory effect. These findings demonstrate that AR has
an Rb-dependent anti-proliferative function, which may be compromised in CRPC cells with Rb-deficiency and
could be enhanced by blocking Rb phosphorylation. The objective of this proposal is to determine the function
roles of AR recruitment of Rb in regulating transcription of DNA replication genes and cell cycle progression of
PCa tumor cells (specific aim 1), to determine the molecular basis for AR interaction with hypophosphorylated
Rb and characterize the distinct Rb complex recruited by AR to the suppression sits (specific aim 2), and to
conduct a genome wide analysis to identify Rb dependent AR suppression sites and determine the mechanism
of actions and function roles of these sites in prostate cancer cells (specific aim 3).
项目摘要
虽然AR已被广泛表征为转录激活剂,但最近报道,
作为转录抑制因子抑制基因的子集。值得注意的是,通过AR ChIP-seq和
在前列腺癌细胞中,我们发现直接AR抑制的基因高度表达,
这些基因中的大多数在CRPC临床中持续增加,
样品然后我们发现AR的这种直接转录抑制活性是由
雄激素刺激的低磷酸化Rb的募集。雄激素也被称为刺激生长,
进一步AR转录激活驱动脂质和固醇合成的基因,以及其他代谢功能,
随后细胞周期蛋白依赖性激酶活化和Rb过度磷酸化。AR的过度表达
前列腺癌细胞可以克服这种生长刺激作用。这些发现表明,AR具有
Rb依赖性抗增殖功能,其可能在Rb缺乏的CRPC细胞中受损,
可以通过阻断Rb磷酸化来增强。本提案的目的是确定
Rb的AR募集在调节DNA复制基因转录和细胞周期进程中的作用
PCa肿瘤细胞(特定目的1),以确定AR与低磷酸化
Rb和表征由AR募集到抑制位点的不同Rb复合物(特异性目的2),以及
进行全基因组分析以鉴定Rb依赖性AR抑制位点并确定其机制
这些位点在前列腺癌细胞中的作用和功能作用(具体目标3)。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Novel Mechanism to Induce BRCAness in Cancer Cells.
- DOI:10.1158/0008-5472.can-20-1451
- 发表时间:2020-07-15
- 期刊:
- 影响因子:11.2
- 作者:Cai C
- 通讯作者:Cai C
Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2.
在castration-抗性前列腺癌中增加的AR表达迅速诱导AR信号传导与EZH2的协作重编程。
- DOI:10.3389/fonc.2022.1021845
- 发表时间:2022
- 期刊:
- 影响因子:4.7
- 作者:
- 通讯作者:
Pioneer of prostate cancer: past, present and the future of FOXA1.
- DOI:10.1007/s13238-020-00786-8
- 发表时间:2021-01
- 期刊:
- 影响因子:21.1
- 作者:Teng M;Zhou S;Cai C;Lupien M;He HH
- 通讯作者:He HH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Changmeng Cai其他文献
Changmeng Cai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Changmeng Cai', 18)}}的其他基金
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication
视网膜母细胞瘤蛋白介导的雄激素受体转录抑制活性对DNA复制的机制研究
- 批准号:
9756340 - 财政年份:2017
- 资助金额:
$ 34.88万 - 项目类别:
Molecular basis of androgen receptor mediated gene transcriptional repression
雄激素受体介导的基因转录抑制的分子基础
- 批准号:
9068848 - 财政年份:2015
- 资助金额:
$ 34.88万 - 项目类别:
Molecular basis of androgen receptor mediated gene transcriptional repression
雄激素受体介导的基因转录抑制的分子基础
- 批准号:
9062577 - 财政年份:2015
- 资助金额:
$ 34.88万 - 项目类别:
Molecular basis of androgen receptor mediated gene transcriptional repression
雄激素受体介导的基因转录抑制的分子基础
- 批准号:
8280048 - 财政年份:2012
- 资助金额:
$ 34.88万 - 项目类别:
Molecular basis of androgen receptor mediated gene transcriptional repression
雄激素受体介导的基因转录抑制的分子基础
- 批准号:
8533770 - 财政年份:2012
- 资助金额:
$ 34.88万 - 项目类别:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
靶向非洲血统男性前列腺癌中的雄激素受体信号传导
- 批准号:
10490378 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
靶向非洲血统男性前列腺癌中的雄激素受体信号传导
- 批准号:
10327764 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
靶向非洲血统男性前列腺癌中的雄激素受体信号传导
- 批准号:
10704700 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
相似海外基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
- 批准号:
10418461 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
- 批准号:
RGPIN-2019-04999 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Discovery Grants Program - Individual
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10570208 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10355174 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
- 批准号:
2744296 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10525097 - 财政年份:2022
- 资助金额:
$ 34.88万 - 项目类别: